Dp. Gately et al., INDUCTION OF THE GROWTH ARREST AND DNA DAMAGE-INDUCIBLE GENE GADD153 BY CISPLATIN IN-VITRO AND IN-VIVO, British Journal of Cancer, 70(6), 1994, pp. 1102-1106
The inability to assess the extent of tumour damage immediately follow
ing treatment is a major clinical obstacle to improving the management
of cancer patients. Normally, the effectiveness of chemotherapy or ra
diation therapy cannot be determined for at least several weeks after
treatment. We studied the increase in mRNA of the growth arrest and DN
A damage-inducible gene GADD153 in human 2008 ovarian carcinoma cells
in vitro and in vivo to determine whether treatment-induced increases
in the level of GADD153 mRNA could be used as a marker of the extent o
f tumour damage. GADD153 mRNA was increased in a transient, dose-depen
dent manner by cisplatin (DDP) when the tumour cells were grown both i
n vitro and as tumour xenografts in nude mice. The magnitude of induct
ion of GADD153 mRNA did not vary significantly between different 2008
xenografts treated with equal doses of DDP, and GADD153 mRNA induction
correlated with the degree of in vitro cytotoxicity for two different
schedules of drug exposure. DDP increased GADD153 mRNA levels in mela
noma and head and neck xenograft models as well. We conclude that the
increase in GADD153 mRNA can be used to detect tumour injury at time p
oints as short as 24 h after administration of DDP.